查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球牙科麻醉剂市场（按药物类型、给药途径、最终用户和地区划分）- 预测至 2030 年
市场调查报告书
商品编码
1727400

全球牙科麻醉剂市场（按药物类型、给药途径、最终用户和地区划分）- 预测至 2030 年

Dental Anesthetics Market by Drug Type (Lidocaine, Mepivacaine, Articaine, Bupivacaine, Mepivacaine, Prilocaine), Route of Administration (Topical, Injectable, Syringes, Needles), End User (Hospitals, Clinics, Others), Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 245 Pages | 订单完成后即时交付

价格

全球牙科麻醉剂市场规模预计将从 2025 年的 14.8 亿美元成长到 2030 年的 18 亿美元，预测期内的复合年增长率为 4.0%。

研究范围
调查年份 2024-2030
基准年 2024
预测期 2024-2030
对价单位 金额（十亿美元）
部分 依药物类型、给药途径、最终用户和地区
目标区域 北美、欧洲、亚太地区、世界其他地区

由于牙科疾病盛行率的上升和牙科手术的增加，全球牙科麻醉剂市场正在扩大。此外，人们对口腔健康和美容牙科重要性的认识不断提高，导致越来越多的人接受牙科治疗。许多地区收入水准的提高和医疗基础设施的改善使得牙科护理变得更加容易获得。此外，预计老年人口的成长将推动对这些服务的需求。然而，在预测期内，牙医短缺和牙科治疗保险覆盖范围有限等挑战可能会在一定程度上阻碍市场成长。

由于与其他类型的麻醉剂相比具有众多优势，预计Articaine在预测期内将经历最高的复合年增长率。与其他含有苯环的酰胺麻醉剂不同，Articaine具有硫酚吩环，增加了其脂溶性并提高了其对组织和神经膜的渗透性。这种透过硬组织和软组织的增强扩散使Articaine对于渗透下颚骨特别有效，而该部位的神经阻断通常需要与其他麻醉剂一起使用。因此，牙医发现Articaine在骨骼密度较高的区域效果较好。此外，多项研究已证实，在老年和儿科患者群体中适当使用时，它是安全的。这些优势促进了Articaine的日益普及，并支持了其市场扩张。

局部麻醉剂市场预计将见证牙科麻醉剂市场的最高成长，这得益于其在标准程序中的广泛使用、易于应用、非侵入性以及提供快速表面麻醉的能力。牙医越来越多地使用凝胶、定量喷雾和贴片等新技术。此外，无针麻醉的引入和各种局部麻醉剂的出现也促进了麻醉的采用率的提高。儘管局部麻醉剂的作用时间较短，但其可靠性和广泛的应用范围继续推动市场成长。

牙科麻醉剂的需求主要受到拉丁美洲和亚太地区发展中地区牙科诊所成长的推动。随着越南、印尼和印度等国家的牙科服务变得越来越普及，越来越多的患者正在寻求需要有效疼痛管理的手术。推动牙科诊所扩张的主要因素包括中等收入群体收入的提高、都市化以及口腔卫生意识的增强。因此，对可靠的局部和麻醉剂的需求日益增加。

由于反映医疗保健变化的多种因素，亚太地区的牙科麻醉剂市场预计将以最高的复合年增长率成长。牙齿感染疾病盛行率的上升和人们对口腔健康的认识的提高推动了牙科治疗的需求。此外，该地区人口数量庞大且老化是医疗支出上升的主要原因，推动了对易于获取且对患者友好的治疗方案的需求。医疗保健基础设施的改善、可支配收入的增加以及牙科麻醉剂的进步也有望推动亚太地区牙科麻醉剂市场的成长。

本报告研究了全球牙科麻醉剂市场，并根据药物类型、给药途径、最终用户、区域趋势和参与市场的公司概况对其进行细分。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章重要考察

第五章市场概述

  • 介绍
  • 市场动态
  • 波特五力分析
  • 监管分析
  • 产业趋势
  • 赎回方案
  • 技术分析
  • 2025-2026 年重要会议与活动
  • 定价分析
  • 贸易分析
  • 专利分析
  • 价值链分析
  • 生态系分析
  • 供应链分析
  • 案例研究分析
  • 影响客户业务的趋势/中断
  • 主要相关人员和采购标准
  • 邻近市场分析
  • 未满足的需求/最终用户期望
  • 人工智慧/产生人工智慧对牙科麻醉市场的影响
  • 2025年美国关税的影响—概述

6. 牙科麻醉剂市场（依药物类型）

  • 介绍
  • Lidocaine
  • Mepivacaine
  • 阿替卡因
  • Bupivacaine
  • Prilocaine
  • 其他的

第7章 牙科麻醉剂市场（依给药途径）

  • 介绍
  • 局部麻醉剂
  • 注射麻醉剂
  • 注射器
  • 针

8. 牙科麻醉剂市场（依最终用户划分）

  • 介绍
  • 医院
  • 牙医诊所
  • 其他的

第九章牙科麻醉剂市场（按地区）

  • 介绍
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 英国
    • 其他的
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 亚太地区
    • 亚太宏观经济展望
    • 韩国
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 其他的
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场扩张使人们更加关注服务不足的地区
    • 中东和非洲宏观经济展望
  • 海湾合作委员会国家
    • 加强公共宣传活动和教育项目以刺激市场
    • 海湾合作委员会国家的宏观经济展望

第十章 竞争格局

  • 介绍
  • 主要参与企业的策略/优势
  • 市场占有率分析
  • 公司估值矩阵：2024 年主要参与企业
  • 公司估值矩阵：Start-Ups/中小企业，2024 年
  • 估值和财务指标
  • 品牌/产品比较
  • 竞争场景

第十一章 公司简介

  • 主要参与企业
    • SEPTODONT HOLDING
    • DENTSPLY SIRONA
    • PIERREL
    • HUONS GLOBAL
    • NORMON
    • DFL INDUSTRIA E COMERCIO S/A
    • ULTRADENT PRODUCTS INC.
    • PRIMEX PHARMACEUTICALS
    • KEYSTONE INDUSTRIES
    • CLARBEN LABORATORIES
    • HIKMA PHARMACEUTICALS PLC
    • ZEYCO
    • NEW STETIC SA
    • CETYLITE, INC.
    • ICPA HEALTH PRODUCTS LIMITED
  • 其他公司
    • CENTRIX, INC.
    • ZYMETH PHARMACEUTICAL
    • DMG AMERICA LLC
    • GC SHOWAYAKUHIN CORPORATION
    • YOUNG INNOVATIONS, INC.
    • CROSSTEX INTERNATIONAL, INC.
    • MARK3（CARGUS INTERNATIONAL, INC.）
    • J. MORITA CORP.
    • KULZER GMBH
    • INTEGRA LIFESCIENCES CORPORATION

第十二章 附录

Product Code: MD 9362

The global dental anesthetics market is projected to reach USD 1.80 billion by 2030 from USD 1.48 billion in 2025, at a CAGR of 4.0% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD billion)
SegmentsDrug Type, Route of Administration, End User, and Region
Regions coveredNorth America, Europe, APAC, RoW

The global market for dental anesthetics is expanding due to a rising incidence of dental issues, which has led to an increase in dental procedures. Furthermore, there is greater awareness of the importance of oral health and cosmetic dentistry, prompting more individuals to seek dental treatments. Improved income levels and enhanced healthcare infrastructure in many regions make dental care more accessible. Additionally, the growing elderly population is expected to drive up demand for these services. However, during the projected period, challenges such as a shortage of dental practitioners and limited insurance coverage for dental procedures may hinder market growth to some extent.

"Articaine is expected to grow at the highest CAGR during the forecast period."

Articaine is projected to experience the highest CAGR during the forecast period due to its numerous advantages over other types of anesthetics. Unlike other amide anesthetics that contain a benzene ring, articaine features a thiophene ring, which leads to increased lipid solubility and improved penetration into tissues and nerve membranes. This enhanced diffusion through both hard and soft tissues makes articaine particularly effective for mandibular infiltrations, where nerve blocks are often required with other anesthetics. Consequently, dentists find that articaine performs better in areas with dense bone structures. Additionally, various studies have confirmed its safety profile when used appropriately, even among elderly and pediatric patient populations. These advantages contribute to the growing popularity of articaine and support its market expansion.

"The topical anesthetics segment is expected to grow at the highest CAGR in the dental anesthetics market, by route of administration."

The topical anesthetics market is projected to experience the highest growth in the dental anesthetics market, driven by their widespread use in standard procedures, ease of application, non-invasiveness, and ability to provide quick surface anesthesia. Dentists increasingly utilize new technologies such as gels, metered-dose sprays, and patches. Additionally, the introduction of needle-free anesthesia and the availability of topical anesthetics in various flavors contribute to their increased adoption. Although topical anesthetics are limited by their short duration of action, their reliability and broad range of applications continue to fuel market growth.

"Based on end users, the dental clinics segment is expected to dominate the dental anesthetics market during the forecast period."

The demand for dental anesthetics is primarily driven by the growth of dental clinics in developing regions of Latin America and the Asia Pacific. As dental services become more accessible in countries such as Vietnam, Indonesia, and India, a greater number of patients are seeking surgeries that require effective pain management. Key factors contributing to the expansion of dental clinics include rising incomes among the middle class, urbanization, and an increasing awareness of oral health. Consequently, there is a growing need for reliable topical and local anesthetics, as more dental clinics now offer restorative and cosmetic procedures.

"The Asia Pacific is expected to register the highest CAGR in the dental anesthetics market during the forecast period."

The dental anesthetics market in the Asia Pacific region is expected to grow at the highest CAGR due to several factors that reflect the changing landscape of healthcare. The rising prevalence of dental infections and greater awareness of oral health drive the demand for dental procedures. Additionally, the region's large and aging population significantly contributes to increased healthcare spending, which boosts the need for easily accessible and patient-friendly treatment options. Improvements in healthcare infrastructure, higher disposable incomes, and advancements in dental anesthetics will also likely fuel growth in the Asia Pacific dental anesthetics market.

A summary of the main supply-side participants in the dental anesthetics market is provided below for this report:

  • By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
  • By Designation: C-level Executives (20%), D-level Executives (35%), and Others (45%)
  • By Region: North America (25%), Europe (23%), Asia Pacific (28%), Latin America (17%), Middle East & Africa (7%)

The prominent players in the global dental anesthetics market are Septodont Holding (France), DENTSPLY SIRONA (US), Pierrel (Italy), Huons Global (South Korea), Normon (Spain), DFL Industria e Comercio S/A (Brazil), Ultradent Products Inc. (US), Hikma Pharmaceuticals Plc (UK), Clarben Laboratories (Spain), New Stetic S.A (Colombia), Primex Pharmaceuticals (Switzerland), Keystone Industries (US), Centrix, Inc. (US), GC SHOWAYAKUHIN CORPORATION (Japan), DMG America LLC (US), Zeyco (Mexico), Zymeth Pharmaceutical (India), Cetylite, Inc. (US), ICPA Health Products Limited (India), Crosstex International, Inc. (US), Young Innovations, Inc. (US), Mark3 (Cargus International, Inc.) (US), J.Morita Corp. (Japan), Kulzer GmbH (Germany), and Integra Lifesciences Corporation (US).

Research Coverage

The market study focuses on the dental anesthetics market across various segments. Its purpose is to estimate the market size and growth potential across different categories, including drug type, route of administration, end user, and geographic region. Additionally, the study includes a comprehensive competitive analysis of the key players in the market, along with their company profiles. This analysis features important observations regarding their product offerings, recent developments, and key strategies in the market.

Reasons to Buy the Report

The report provides valuable information for market leaders and new entrants in the dental anesthetics market, offering approximate revenue figures for both the overall market and its subsegments. It enables stakeholders to understand the competitive landscape, which can help them better position their businesses and develop effective go-to-market strategies. Additionally, the report offers insights into the current state of the market, including critical drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

  • Analysis of key drivers (increasing patient pool for dental treatments, increasing demand for advanced cosmetic dental procedures, and technological advancements in anesthetic delivery), restraints (potential adverse effects), opportunities (rising number of DSOs and growing private equity investments, emerging markets, and growing dental tourism) and challenges (dearth of trained dental practitioners and needle phobia).
  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global dental anesthetics market. The report analyzes this market by drug type, route of administration, end user, and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global dental anesthetics market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by drug type, route of administration, end user, and region.
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global dental anesthetics market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 UNIT CONSIDERED
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 SCOPE-RELATED LIMITATIONS
    • 2.6.2 METHODOLOGY-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 DENTAL ANESTHETICS MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION AND COUNTRY (2024)
  • 4.3 DENTAL ANESTHETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 DENTAL ANESTHETICS MARKET: REGIONAL MIX
  • 4.5 DENTAL ANESTHETICS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing patient pool for dental treatments
        • 5.2.1.1.1 Dental caries and other dental disorders
        • 5.2.1.1.2 Geriatric population and edentulism
        • 5.2.1.1.3 Periodontal diseases
        • 5.2.1.1.4 Changing lifestyles and unhealthy food habits
      • 5.2.1.2 Increasing demand for advanced cosmetic dental procedures
      • 5.2.1.3 Technological advancements in anesthetic delivery
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Potential adverse effects
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising number of DSOs and growing private equity investments
      • 5.2.3.2 Emerging markets
      • 5.2.3.3 Growing dental tourism
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of trained dental practitioners
      • 5.2.4.2 Needle phobia
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.3.2 BARGAINING POWER OF SUPPLIERS
    • 5.3.3 BARGAINING POWER OF BUYERS
    • 5.3.4 THREAT OF SUBSTITUTES
    • 5.3.5 THREAT OF NEW ENTRANTS
  • 5.4 REGULATORY ANALYSIS
    • 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.4.2 REGULATORY LANDSCAPE
  • 5.5 INDUSTRY TRENDS
    • 5.5.1 METERED SPRAY SYSTEMS
    • 5.5.2 JET INJECTION SYSTEMS
  • 5.6 REIMBURSEMENT SCENARIO
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 KEY TECHNOLOGIES
      • 5.7.1.1 Vasoconstrictors
      • 5.7.1.2 Buffering agents
    • 5.7.2 COMPLEMENTARY TECHNOLOGIES
      • 5.7.2.1 Computer-controlled local anesthetic delivery (CCLAD) systems
    • 5.7.3 ADJACENT TECHNOLOGIES
      • 5.7.3.1 Reversal agents
  • 5.8 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.9 PRICING ANALYSIS
    • 5.9.1 AVERAGE SELLING PRICE TREND OF INJECTABLE ANESTHETICS, BY REGION
    • 5.9.2 INDICATIVE SELLING PRICE OF DENTAL ANESTHETICS, BY KEY PLAYER
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020-2024
    • 5.10.2 EXPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020-2024
  • 5.11 PATENT ANALYSIS
    • 5.11.1 PATENT PUBLICATION TRENDS FOR DENTAL ANESTHETICS
    • 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN DENTAL ANESTHETICS MARKET
  • 5.12 VALUE CHAIN ANALYSIS
  • 5.13 ECOSYSTEM ANALYSIS
  • 5.14 SUPPLY CHAIN ANALYSIS
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 CASE STUDY 1: ORAQIX TOPICAL ANESTHETIC SIGNIFICANTLY REDUCED PAIN DURING SRP, ENHANCING COMFORT AND PATIENT ACCEPTANCE OF PERIODONTAL THERAPY
    • 5.15.2 CASE STUDY 2: PROCAINE HYDROCHLORIDE PROVIDES SAFE DENTAL ANESTHESIA FOR PATIENT WITH LIDOCAINE ALLERGIES AND SEVERE PHOBIA
    • 5.15.3 CASE STUDY 3: COMPUTERIZED ANESTHESIA SYSTEM AND PATIENT EDUCATION REDUCE DENTAL ANXIETY IN EXTRACTION PROCEDURES
  • 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.17 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.17.2 BUYING CRITERIA
  • 5.18 ADJACENT MARKET ANALYSIS
  • 5.19 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.20 IMPACT OF AI/GENERATIVE AI ON DENTAL ANESTHETICS MARKET
  • 5.21 IMPACT OF 2025 US TARIFF - OVERVIEW
    • 5.21.1 INTRODUCTION
    • 5.21.2 KEY TARIFF RATES
    • 5.21.3 PRICE IMPACT ANALYSIS
    • 5.21.4 IMPACT ON END-USER INDUSTRIES

6 DENTAL ANESTHETICS MARKET, BY DRUG TYPE

  • 6.1 INTRODUCTION
  • 6.2 LIDOCAINE
    • 6.2.1 RAPID ONSET AND VERSATILE FORMULATIONS TO DRIVE MARKET
  • 6.3 MEPIVACAINE
    • 6.3.1 UPTAKE IN PEDIATRIC & GERIATRIC POPULATIONS TO FUEL MARKET
  • 6.4 ARTICAINE
    • 6.4.1 IDEAL CHOICE FOR EXTENDED SURGICAL PROCEDURES TO PROPEL MARKET
  • 6.5 BUPIVACAINE
    • 6.5.1 PROVISION OF EFFECTIVE POST-OPERATIVE PAIN RELIEF TO SUPPORT MARKET GROWTH
  • 6.6 PRILOCAINE
    • 6.6.1 LOWER TOXICITY PROFILE TO FUEL UPTAKE
  • 6.7 OTHER DRUG TYPES

7 DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION

  • 7.1 INTRODUCTION
  • 7.2 TOPICAL ANESTHETICS
    • 7.2.1 GROWING PATIENT PREFERENCE FOR NEEDLE-FREE ALTERNATIVES TO BOOST DEMAND
  • 7.3 INJECTABLE ANESTHETICS
    • 7.3.1 HIGH PRECISION AND EFFECTIVENESS TO PROPEL MARKET
  • 7.4 SYRINGES
    • 7.4.1 ADVANCEMENTS IN SYRINGE DESIGN TO FUEL MARKET
  • 7.5 NEEDLES
    • 7.5.1 RISING FOCUS ON INFECTION CONTROL AND PATIENT COMFORT TO SUPPORT MARKET GROWTH

8 DENTAL ANESTHETICS MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    • 8.2.1 ABILITY TO PURCHASE ADVANCED DENTISTRY EQUIPMENT TO DRIVE MARKET
  • 8.3 DENTAL CLINICS
    • 8.3.1 RISING DEMAND FOR COSMETIC & RESTORATIVE DENTAL PROCEDURES TO PROPEL MARKET
  • 8.4 OTHER END USERS

9 DENTAL ANESTHETICS MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 EUROPE
    • 9.2.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.2.2 GERMANY
      • 9.2.2.1 Favorable government policies for reimbursement to expedite growth
    • 9.2.3 ITALY
      • 9.2.3.1 Rising adoption of digital dentistry techniques to augment growth
    • 9.2.4 SPAIN
      • 9.2.4.1 Presence of well-established dental healthcare infrastructure to foster growth
    • 9.2.5 FRANCE
      • 9.2.5.1 Favorable distribution network and reimbursement scenario to aid growth
    • 9.2.6 UK
      • 9.2.6.1 Booming geriatric population to stimulate growth
    • 9.2.7 REST OF EUROPE
  • 9.3 NORTH AMERICA
    • 9.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.3.2 US
      • 9.3.2.1 High per capita income and quality of treatment to support growth
    • 9.3.3 CANADA
      • 9.3.3.1 Rising healthcare expenditure to sustain growth
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 SOUTH KOREA
      • 9.4.2.1 Growing elderly population to fuel market
    • 9.4.3 JAPAN
      • 9.4.3.1 Surge in age-related dental issues to promote growth
    • 9.4.4 CHINA
      • 9.4.4.1 Shift in demographic trend to accelerate growth
    • 9.4.5 INDIA
      • 9.4.5.1 Growing cosmetic dentistry sector to fuel market
    • 9.4.6 AUSTRALIA
      • 9.4.6.1 Increasing access to dental services to favor growth
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Booming dental tourism to contribute to growth
    • 9.5.3 ARGENTINA
      • 9.5.3.1 Growing focus on oral health to propel market
    • 9.5.4 MEXICO
      • 9.5.4.1 Affordable dental care costs to amplify growth
    • 9.5.5 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GROWING FOCUS ON UNDERSERVED AREAS TO BOOST MARKET
    • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.7 GCC COUNTRIES
    • 9.7.1 INCREASING NUMBER OF PUBLIC CAMPAIGNS AND EDUCATION PROGRAMS TO DRIVE MARKET
    • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL ANESTHETICS MARKET
  • 10.3 MARKET SHARE ANALYSIS
  • 10.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.4.1 STARS
    • 10.4.2 EMERGING LEADERS
    • 10.4.3 PERVASIVE PLAYERS
    • 10.4.4 PARTICIPANTS
    • 10.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 10.4.5.1 Company footprint
      • 10.4.5.2 Region footprint
      • 10.4.5.3 Drug type footprint
      • 10.4.5.4 Route of administration footprint
  • 10.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 10.5.1 PROGRESSIVE COMPANIES
    • 10.5.2 RESPONSIVE COMPANIES
    • 10.5.3 DYNAMIC COMPANIES
    • 10.5.4 STARTING BLOCKS
    • 10.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 10.5.5.1 Detailed list of key startups/SMEs
      • 10.5.5.2 Competitive benchmarking of key startups/SMEs
  • 10.6 COMPANY VALUATION & FINANCIAL METRICS
    • 10.6.1 FINANCIAL METRICS
    • 10.6.2 COMPANY VALUATION
  • 10.7 BRAND/PRODUCT COMPARISON
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 PRODUCT LAUNCHES
    • 10.8.2 DEALS
    • 10.8.3 EXPANSIONS
    • 10.8.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 SEPTODONT HOLDING
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products/Services/Solutions offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product launches
        • 11.1.1.3.2 Deals
        • 11.1.1.3.3 Expansions
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 DENTSPLY SIRONA
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products/Services/Solutions offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Deals
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 PIERREL
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products/Services/Solutions offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product launches
        • 11.1.3.3.2 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 HUONS GLOBAL
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products/Services/Solutions offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Expansions
        • 11.1.4.3.2 Other developments
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Right to win
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses & competitive threats
    • 11.1.5 NORMON
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products/Services/Solutions offered
      • 11.1.5.3 MnM view
        • 11.1.5.3.1 Right to win
        • 11.1.5.3.2 Strategic choices
        • 11.1.5.3.3 Weaknesses & competitive threats
    • 11.1.6 DFL INDUSTRIA E COMERCIO S/A
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products/Services/Solutions offered
    • 11.1.7 ULTRADENT PRODUCTS INC.
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products/Services/Solutions offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Deals
        • 11.1.7.3.2 Expansions
        • 11.1.7.3.3 Other developments
    • 11.1.8 PRIMEX PHARMACEUTICALS
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products/Services/Solutions offered
    • 11.1.9 KEYSTONE INDUSTRIES
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products/Services/Solutions offered
    • 11.1.10 CLARBEN LABORATORIES
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products/Services/Solutions offered
    • 11.1.11 HIKMA PHARMACEUTICALS PLC
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products/Services/Solutions offered
    • 11.1.12 ZEYCO
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products/Services/Solutions offered
    • 11.1.13 NEW STETIC S.A.
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products/Services/Solutions offered
    • 11.1.14 CETYLITE, INC.
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products/Services/Solutions offered
    • 11.1.15 ICPA HEALTH PRODUCTS LIMITED
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products/Services/Solutions offered
  • 11.2 OTHER PLAYERS
    • 11.2.1 CENTRIX, INC.
    • 11.2.2 ZYMETH PHARMACEUTICAL
    • 11.2.3 DMG AMERICA LLC
    • 11.2.4 GC SHOWAYAKUHIN CORPORATION
    • 11.2.5 YOUNG INNOVATIONS, INC.
    • 11.2.6 CROSSTEX INTERNATIONAL, INC.
    • 11.2.7 MARK3 (CARGUS INTERNATIONAL, INC.)
    • 11.2.8 J. MORITA CORP.
    • 11.2.9 KULZER GMBH
    • 11.2.10 INTEGRA LIFESCIENCES CORPORATION

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • TABLE 2 DENTAL ANESTHETICS MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 3 PROJECTED INCREASE IN NUMBER OF PEOPLE AGED OVER 65 YEARS, BY REGION, 2019 VS. 2050 (MILLION)
  • TABLE 4 US: AVERAGE SPENDING BY PATIENTS ON COSMETIC DENTISTRY SERVICES, 2021 VS. 2022
  • TABLE 5 US: RECENT DEALS BACKED BY PRIVATE EQUITY, 2020-2024
  • TABLE 6 AVERAGE PROCEDURAL COST IN TOP TEN DENTAL TOURISM DESTINATIONS (USD)
  • TABLE 7 DENTAL ANESTHETICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 DENTAL ANESTHETICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025-2026
  • TABLE 14 AVERAGE SELLING PRICE TREND OF INJECTABLE ANESTHETICS, BY REGION, 2023-2025 (USD)
  • TABLE 15 INDICATIVE SELLING PRICE OF DENTAL ANESTHETICS, BY KEY PLAYER, 2024
  • TABLE 16 IMPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 17 EXPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), BY COUNTRY, 2020-2024 (USD THOUSAND)
  • TABLE 18 LIST OF PATENTS IN DENTAL ANESTHETICS MARKET (2022-2024)
  • TABLE 19 DENTAL ANESTHETICS MARKET: ROLE IN ECOSYSTEM
  • TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS
  • TABLE 21 KEY BUYING CRITERIA FOR END USERS
  • TABLE 22 DENTAL ANESTHETICS MARKET: UNMET NEEDS
  • TABLE 23 DENTAL ANESTHETICS MARKET: END-USER EXPECTATIONS
  • TABLE 24 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 25 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR DENTAL PRODUCTS
  • TABLE 26 DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 27 DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 28 DENTAL ANESTHETICS MARKET FOR LIDOCAINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 29 DENTAL ANESTHETICS MARKET FOR MEPIVACAINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 DENTAL ANESTHETICS MARKET FOR ARTICAINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 DENTAL ANESTHETICS MARKET FOR BUPIVACAINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 32 DENTAL ANESTHETICS MARKET FOR PRILOCAINE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 33 DENTAL ANESTHETICS MARKET FOR OTHER DRUG TYPES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 35 DENTAL ANESTHETICS MARKET FOR ROUTE OF ADMINISTRATION, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 TOPICAL ANESTHETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 INJECTABLE ANESTHETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 INJECTABLE ANESTHETICS MARKET, BY REGION, 2023-2030 (THOUSAND UNITS)
  • TABLE 39 SYRINGES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 NEEDLES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 42 DENTAL ANESTHETICS MARKET FOR HOSPITALS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 DENTAL ANESTHETICS MARKET FOR DENTAL CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 DENTAL ANESTHETICS MARKET FOR OTHER END USERS, BY COUNTRY 2023-2030 (USD MILLION)
  • TABLE 45 DENTAL ANESTHETICS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 EUROPE: DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 47 EUROPE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 48 EUROPE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 49 EUROPE: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 50 GERMANY: DENTIST POPULATION, 2019-2022
  • TABLE 51 GERMANY: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 52 GERMANY: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 53 GERMANY: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 54 GERMANY: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 55 ITALY: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 56 ITALY: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 57 ITALY: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 58 ITALY: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 59 SPAIN: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 60 SPAIN: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 61 SPAIN: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 62 SPAIN: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 63 FRANCE: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 64 FRANCE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 65 FRANCE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 66 FRANCE: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 67 UK: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 68 UK: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 69 UK: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 70 UK: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 71 REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 72 REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 73 REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 74 US: DENTAL EXPENDITURE, 2014-2023 (USD BILLION)
  • TABLE 75 NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 77 NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 78 NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 79 US: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 80 US: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 81 US: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 82 CANADA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 83 CANADA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 84 CANADA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 85 CANADA: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 86 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 87 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 89 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 90 SOUTH KOREA: FOREIGN PATIENTS VISITING DENTAL FACILITIES, 2017-2021
  • TABLE 91 SOUTH KOREA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 92 SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 93 SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 94 SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 95 JAPAN: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 96 JAPAN: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 97 JAPAN: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 98 JAPAN: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 99 CHINA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 100 CHINA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 101 CHINA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 102 CHINA: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 103 INDIA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 104 INDIA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 INDIA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 106 INDIA: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 107 AUSTRALIA: MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 108 AUSTRALIA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 109 AUSTRALIA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 110 AUSTRALIA: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 111 REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 112 REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 113 REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 114 LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 115 LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 116 LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 117 LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 118 BRAZIL: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 119 BRAZIL: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 120 BRAZIL: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 121 BRAZIL: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 122 ARGENTINA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 123 ARGENTINA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 124 ARGENTINA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 125 ARGENTINA: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 126 MEXICO: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
  • TABLE 127 MEXICO: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 128 MEXICO: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 129 MEXICO: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 130 REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 131 REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 132 REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 133 MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
  • TABLE 134 MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 135 MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 136 GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023- 2030 (USD MILLION)
  • TABLE 137 GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
  • TABLE 138 GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 139 STRATEGIES ADOPTED BY KEY PLAYERS IN DENTAL ANESTHETICS MARKET, JANUARY 2021-MARCH 2025
  • TABLE 140 DENTAL ANESTHETICS MARKET: DEGREE OF COMPETITION
  • TABLE 141 DENTAL ANESTHETICS MARKET: REGION FOOTPRINT
  • TABLE 142 DENTAL ANESTHETICS MARKET: DRUG TYPE FOOTPRINT
  • TABLE 143 DENTAL ANESTHETICS MARKET: ROUTE OF ADMINISTRATION FOOTPRINT
  • TABLE 144 DENTAL ANESTHETICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 145 DENTAL ANESTHETICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 146 DENTAL ANESTHETICS MARKET: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2025
  • TABLE 147 DENTAL ANESTHETICS MARKET: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 148 DENTAL ANESTHETICS MARKET: EXPANSIONS, JANUARY 2021-MARCH 2025
  • TABLE 149 DENTAL ANESTHETICS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-MARCH 2025
  • TABLE 150 SEPTODONT HOLDING: COMPANY OVERVIEW
  • TABLE 151 SEPTODONT HOLDING: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 152 SEPTODONT HOLDING: PRODUCTS LAUNCHES, JANUARY 2021-MARCH 2025
  • TABLE 153 SEPTODONT HOLDING: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 154 SEPTODONT HOLDING: EXPANSIONS, JANUARY 2021-MARCH 2025
  • TABLE 155 DENTSPLY SIRONA: COMPANY OVERVIEW
  • TABLE 156 DENTSPLY SIRONA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 157 DENTSPLY SIRONA: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 158 PIERREL: COMPANY OVERVIEW
  • TABLE 159 PIERREL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 160 PIERREL: PRODUCT LAUNCHES, JANUARY 2021-MARCH 2025
  • TABLE 161 PIERREL: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 162 HUONS GLOBAL: COMPANY OVERVIEW
  • TABLE 163 HUONS GLOBAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 164 HUONS GLOBAL: EXPANSIONS, JANUARY 2021-MARCH 2025
  • TABLE 165 HUONS GLOBAL: OTHER DEVELOPMENTS, JANUARY 2021-MARCH 2025
  • TABLE 166 NORMON: COMPANY OVERVIEW
  • TABLE 167 NORMON: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 168 DFL INDUSTRIA E COMERCIO S/A: COMPANY OVERVIEW
  • TABLE 169 DFL INDUSTRIA E COMERCIO S/A: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 170 ULTRADENT PRODUCTS INC.: COMPANY OVERVIEW
  • TABLE 171 ULTRADENT PRODUCTS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 172 ULTRADENT PRODUCTS INC.: DEALS, JANUARY 2021-MARCH 2025
  • TABLE 173 ULTRADENT PRODUCTS INC.: EXPANSIONS, JANUARY 2021-MARCH 2025
  • TABLE 174 ULTRADENT PRODUCTS INC.: OTHER DEVELOPMENTS, JANUARY 2021-MARCH 2025
  • TABLE 175 PRIMEX PHARMACEUTICALS: COMPANY OVERVIEW
  • TABLE 176 PRIMEX PHARMACEUTICALS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 177 KEYSTONE INDUSTRIES: COMPANY OVERVIEW
  • TABLE 178 KEYSTONE INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 179 CLARBEN LABORATORIES: COMPANY OVERVIEW
  • TABLE 180 CLARBEN LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 181 HIKMA PHARMACEUTICALS PLC: COMPANY OVERVIEW
  • TABLE 182 HIKMA PHARMACEUTICALS PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 183 ZEYCO: COMPANY OVERVIEW
  • TABLE 184 ZEYCO: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 185 NEW STETIC S.A.: COMPANY OVERVIEW
  • TABLE 186 NEW STETIC S.A.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 187 CETYLITE, INC.: COMPANY OVERVIEW
  • TABLE 188 CETYLITE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 189 ICPA HEALTH PRODUCTS LIMITED: COMPANY OVERVIEW
  • TABLE 190 ICPA HEALTH PRODUCTS LIMITED: PRODUCTS/SERVICES/SOLUTIONS OFFERED
  • TABLE 191 CENTRIX, INC.: COMPANY OVERVIEW
  • TABLE 192 ZYMETH PHARMACEUTICAL: COMPANY OVERVIEW
  • TABLE 193 DMG AMERICA LLC: COMPANY OVERVIEW
  • TABLE 194 GC SHOWAYAKUHIN CORPORATION: COMPANY OVERVIEW
  • TABLE 195 YOUNG INNOVATIONS, INC.: COMPANY OVERVIEW
  • TABLE 196 CROSSTEX INTERNATIONAL, INC.: COMPANY OVERVIEW
  • TABLE 197 MARK3 (CARGUS INTERNATIONAL, INC.): COMPANY OVERVIEW
  • TABLE 198 J. MORITA CORP.: COMPANY OVERVIEW
  • TABLE 199 KULZER GMBH: COMPANY OVERVIEW
  • TABLE 200 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 DENTAL ANESTHETICS MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: SEPTODONT HOLDING
  • FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: DENTAL ANESTHETICS MARKET (2024)
  • FIGURE 10 BOTTOM-UP APPROACH
  • FIGURE 11 TOP-DOWN APPROACH
  • FIGURE 12 CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS (2025-2030)
  • FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 14 DATA TRIANGULATION METHODOLOGY
  • FIGURE 15 DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 DENTAL ANESTHETICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 GEOGRAPHIC SNAPSHOT OF DENTAL ANESTHETICS MARKET
  • FIGURE 19 RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET
  • FIGURE 20 INJECTABLE ANESTHETICS SEGMENT IN SOUTH KOREA LED ASIA PACIFIC MARKET IN 2024
  • FIGURE 21 INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 22 ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 24 DENTAL ANESTHETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 UK: PROJECTED NUMBER OF ADULTS (16 YEARS AND OLDER) WITH DENTAL CARIES, 2020-2050 (MILLION)
  • FIGURE 26 DENTAL ANESTHETICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 27 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL ANESTHETICS MARKET (JANUARY 2014-DECEMBER 2024)
  • FIGURE 28 TOP PATENT APPLICANT COUNTRIES FOR DENTAL ANESTHETICS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 29 DENTAL ANESTHETICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 30 DENTAL ANESTHETICS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 DENTAL ANESTHETICS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 32 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES IN DENTAL ANESTHETICS MARKET
  • FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS
  • FIGURE 34 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 35 DENTAL ANESTHETICS MARKET: ADJACENT MARKET ANALYSIS
  • FIGURE 36 DENTAL ANESTHETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 37 EUROPE: DENTAL ANESTHETICS MARKET SNAPSHOT
  • FIGURE 38 NORTH AMERICA: DENTAL ANESTHETICS MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: DENTAL ANESTHETICS MARKET SNAPSHOT
  • FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN DENTAL ANESTHETICS MARKET (2024)
  • FIGURE 41 DENTAL ANESTHETICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 42 DENTAL ANESTHETICS MARKET: COMPANY FOOTPRINT
  • FIGURE 43 DENTAL ANESTHETICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 44 EV/EBITDA OF KEY VENDORS
  • FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 46 DENTAL ANESTHETICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 47 DENTSPLY SIRONA: COMPANY SNAPSHOT
  • FIGURE 48 HUONS GLOBAL: COMPANY SNAPSHOT
  • FIGURE 49 HIKMA PHARMACEUTICALS PLC: COMPANY SNAPSHOT